Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
PainChek Ltd ( (AU:PCK) ) just unveiled an announcement.
PainChek Ltd has announced the issuance of 276,747 fully paid ordinary shares, which will be quoted on the Australian Securities Exchange (ASX). This move is part of the company’s strategy to enhance its market presence and potentially increase its shareholder base, reflecting its ongoing efforts to expand its operations and strengthen its position in the healthcare technology sector.
More about PainChek Ltd
PainChek Ltd operates in the healthcare technology industry, focusing on developing innovative pain assessment solutions. The company is known for its digital pain assessment tool, which utilizes artificial intelligence to evaluate pain levels in individuals who cannot communicate effectively, such as those with dementia or young children.
Average Trading Volume: 4,916,379
Technical Sentiment Signal: Sell
Current Market Cap: A$77.25M
See more data about PCK stock on TipRanks’ Stock Analysis page.